PepGen Future Growth
Future criteria checks 2/6
PepGen is forecast to grow earnings and revenue by 14.9% and 66.1% per annum respectively while EPS is expected to grow by 30.8% per annum.
Key information
14.9%
Earnings growth rate
30.8%
EPS growth rate
| Biotechs earnings growth | 30.3% |
| Revenue growth rate | 66.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Aug 2024 |
Recent future growth updates
Recent updates
PepGen (NASDAQ:PEPG) Is In A Good Position To Deliver On Growth Plans
Aug 06
PepGen: EDOs Could Enhance Dystrophin Expression Beyond Scope Of Current Treatments
Jul 31The Prognosis For PepGen
May 20PepGen: Long Road Ahead
Jan 20Will PepGen (NASDAQ:PEPG) Spend Its Cash Wisely?
Nov 13Will PepGen (NASDAQ:PEPG) Spend Its Cash Wisely?
Jul 31We Think PepGen (NASDAQ:PEPG) Can Afford To Drive Business Growth
Dec 31Here's Why We're Not Too Worried About PepGen's (NASDAQ:PEPG) Cash Burn Situation
Sep 07PepGen GAAP EPS of -$1.23 misses by $0.47
Aug 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 25 | -98 | -94 | -147 | 3 |
| 12/31/2025 | 5 | -116 | -104 | -125 | 4 |
| 12/31/2024 | N/A | -104 | -96 | -96 | 4 |
| 6/30/2024 | N/A | -89 | -75 | -75 | N/A |
| 3/31/2024 | N/A | -80 | -78 | -76 | N/A |
| 12/31/2023 | N/A | -79 | -72 | -69 | N/A |
| 9/30/2023 | N/A | -74 | -66 | -63 | N/A |
| 6/30/2023 | N/A | -69 | -71 | -67 | N/A |
| 3/31/2023 | N/A | -67 | -66 | -62 | N/A |
| 12/31/2022 | N/A | -69 | -63 | -59 | N/A |
| 9/30/2022 | N/A | -61 | -55 | -52 | N/A |
| 6/30/2022 | N/A | -51 | -41 | -39 | N/A |
| 3/31/2022 | N/A | -39 | -34 | -32 | N/A |
| 12/31/2021 | N/A | -27 | -23 | -23 | N/A |
| 9/30/2021 | N/A | -23 | -17 | -17 | N/A |
| 6/30/2021 | N/A | -15 | -10 | -10 | N/A |
| 3/31/2021 | N/A | -10 | -4 | -4 | N/A |
| 12/31/2020 | N/A | -4 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PEPG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PEPG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PEPG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PEPG's revenue (66.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: PEPG's revenue (66.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PEPG's Return on Equity is forecast to be high in 3 years time